Conference Learning Objectives

Conference Learning Objectives

By the end of the conference, participants will be able to:

  1. Apply pharmacogenomic testing to patient cases and choose an appropriate clinical action.

  2. Explain the data that supports return on investment of pharmacogenomics implementation and testing.

  3. Recognize the challenges related to assessing return on investment and cost savings of pharmacogenomics.

  4. Describe the costs of implementing pharmacogenomics and resources needed.

Pamala Jacobson, PharmD, FCCP

Biography

Conference Chair; Professor and Associate Department Head, Department of Experimental and Clinical Pharmacology, University of Minnesota

Dr. Jacobson received her PharmD from the University of Nebraska and completed residencies, including a specialty residency in infectious disease, at the University of Michigan. She joined the University of Minnesota in 1998.

Pamala Jacobson

Exhibitors-OLD

Exhibitors

Exhibitors are an important part of the biennial pharmacogenomics conference, helping to create awareness of the range of opportunities pertaining to the PGx field. Through your support, your organization will have a unique opportunity to interact with pharmaceutical and medical professionals, pharmacy students, and other interested parties representing health systems and educational institutions worldwide.

 

Accreditation

Accreditation

NCIPE Logo

In support of improving patient care, this activity is planned and implemented by the National Center for I

About the Conference

About the Conference

Since 2016, the University of Minnesota has hosted a biennial national conference on pharmacogenomics. The conference features renowned researchers, expert clinicians and scholars, and leaders from the healthcare provider and payer space, exploring together the most timely issues and challenges faced by those in the field.

Subscribe to